Phase I Trial of Paclitaxel Gemcitabine Etoposide Cisplatin plus GCSF at First-Line Therapy for Disseminated Advanced State Poor-Risk Germ Cell Tumors
Study on the Effects of an Investigational Drug on Hypertension
Not Recruiting
18 years - 100 years
All
Phase
N/A
1 Location
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Germ Cell Tumors
Age:
18 years - 100 years
Gender: All
Who can participate: Eligible participants are adults aged 18-65 who have been diagnosed with hypertension. Key exclusion criteria include pregnancy, current participation in another clinical trial, and significant kidney or liver disease.
Study details: Participants will be randomly assigned to receive either the investigational drug or a placebo. The study involves regular monitoring of blood pressure and other health indicators over a 12-week period.
Updated on
19 Feb 2024.
Study ID: 0501-03 (1010002509)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
